1.. INTRODUCTION {#sec1}
================

In recent years, the increasing numbers of cancer patients and long-term oncological treatments have escalated the emergency admission rates due to both the side effects of the drugs and the clinical symptoms caused by cancer itself in our daily practice. In addition, these patients are concentrated on in-hospital services. Current evaluation criteria are not sufficient in deciding the transition from curative cancer treatments to palliative treatments. Accurate 30-days survival predictions, directing patients to palliative care at the right time will preventboth patients and caregivers from suffering and ensure correct treatments. Survival analyzes should be performed as accurately as possible. The effect of patient data such as clinical, laboratory results, KPS, PPS on survival estimation need to be carefully analyzed.

Prediction of survival is one of the trending research areas for data mining techniques ([@ref1], [@ref2]). Traditional survival models were used such as the Cox proportional hazard model in many studies carried out survival analysis of patients. The logistic regression is widely used to observe the risk conditions among exposure and disease ([@ref3]). Logistic regression is one of the machine learning techniques with statistical background which can be used in binary decisions in medicine such as classification with two classes.

ANN (Artificial Neural Networks) is also a machine learning technique, which imitates the neural system and the design of the brain with neurons and synapses. ANN was used in many outcomes and survival studies. Rughani et al. demonstrated the usefulness of ANN in the survival prediction of patients after brain injury ([@ref4]). Gohari et al. compared the survival prediction performance of the Cox model and ANN in patients with colorectal cancer ([@ref5]). Parsaeian et al. obtained better results using ANN comparing to logistic regression ([@ref6]). Faradmal et al. in predicting breast cancer relapse compared the performance of ANN and log-logistic regression ([@ref7]).

2.. AIM {#sec2}
=======

The purpose of this study is twofold; the first is to determine the predictors of 30-days survival of palliative care cancer patients via ANN and logistic regression models and the second is to predict 30-days survival using the patient data. Performances of two prediction models are compared with the area under the receiver operating characteristic (ROC) curve (AUC).

3.. METHODS {#sec3}
===========

3.1 Data
--------

This investigation was planned based on one-year patient data (n=189) that we followed in the palliative care clinic of our hospital (2017-2018). All data was retrospectively used for this study. The scientific study committee of our hospital reviewed and approved the database for using this study. At the beginning of their hospitalization, all patients are informed that their data could be tracked and their written consent is received. In our palliative care unit of the chest diseases referral center, the patients with advanced COPD (Chronic Obstructive Pulmonary Disease) and interstitial lung diseases are excluded from the study; only cancer cases are included. Most of them were patients with lung cancer who had stopped their advanced oncologic treatment. All patients received supportive treatment regarding their symptom characteristics.

Patient data contain information such as gender, age, symptoms, and signs causing the admission to PCU, the condition of metastasis, biochemical analysis (ALB, CRP, CRP/ALB ratio), hemogram parameters (white, red blood cells, hemoglobin, hematocrit, neutrophil (NE), monocytes, lymphocytes, eosinophil, mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH), mean platelet volume (MPV), platelets (PLT), Neutrophil/Lymphocyte ratio). The patient data of prognostic and symptoms measurements are also available. The tools used are PPS and ESAS. PPS score was modified from the Karnofsky Performance Scale's functional status of ambulation, activity level, evidence of disease, and amounts of self-care oral intake, level of consciousness ([@ref8]-[@ref10]). The ESAS is a validated self-reported tool to measure the nine prevalent symptoms of cancer ([@ref11]). All patient data has been recorded on the first 1-3 days of hospitalization.

Some of the patients died when they were hospitalized. Mortality data of the discharged patients were obtained from the national death notification system after one year (2019). We determined that all of our discharged patients died at the exact time recorded by the national death notification system. All the patients are classified according to their survival time (hospital admission to death) being less or more than thirty days.

3.2 Data Analysis
-----------------

SPSS 23.0 for Windows is used for statistical analysis. Descriptive statistics are revealed as number and percentage for categorical variables and mean, standard deviation, minimum, and maximum for scale variables. Shapiro-Wilk test is used to test the normality assumption. Comparisons of the two independent patient groups are made by Student's t-test when scale variables are normally distributed and when the normality condition is not provided, by the Mann Whitney U test. Comparisons of ratios in independent groups are performed with the Chi-square test. The significance level alpha is accepted as p\<0.05. To examine the relationships, Pearson and Spearman's correlations are used for parametric and non-parametric variables, respectively. All variables with significant correlations are taken as input variables.

For 30-days survival prediction between admission and death, using the significantly correlated factors as input variables, we compared the performances of two classification techniques; logistic regression and ANN. Logistic regression is a linear machine learning method that is used in binary classification problems. It calculates the logarithmic probability of the target variable using a linear function of input variables (independent factors) ([@ref3], [@ref12]).

Another machine learning algorithm is ANN that imitates the synaptic design of the brain. This computational tool enables transferring knowledge or rules concealed in data to the network structure by processing experimental data. An ANN is constructed with three layers: the input layer, hidden layers, and the output layer. All of the input layer nodes are transferred to the output layer in a stratified way. Input layers can be output for the other layer or raw data in the first layer. The main task of the hidden layer is to extract classified information from existing data. The output layer shows the final output of the network. The outputs from the nodes in one layer consist of a weighted linear combination that was transformed by a nonlinear function. This nonlinear function allows the neural network to grasp sophisticated relations between the independent variables and enhance the performance of data-driven machine learning technique ([@ref12]-[@ref14]).

The total dataset is split into a training set, a cross-validation set, and a test set. The training set is used for deriving the parameters related to survivability prediction, the cross-validation set for preventing overfitting, and the test set for evaluating these derived predictors. All significantly correlated variables are used as input data for both ANN and logistic regression classification models. The parameters that affect survival are evaluated by logistic regression and ANN models with a small dataset of patients who live less or more than thirty days. To compare ANN and logistic regression models in our setting, we used the estimated AUC of ROC.

4.. RESULTS {#sec4}
===========

The symptom distributions and palliative prognostic measurements of 189 patients, the majority of which consisted of lung cancers and males, are given in [Table 1](#table1){ref-type="table"}.

###### Characteristics of documented data of patients in PCU (n=189)

                                                                     Mean±SD       Min-Max
  ------------------------------------ ----------------------------- ------------- ---------
  Age                                                                64.53±11.60   26-91
  Karnofsky Performance Status                                       32.86±17.63   10-90
  Edmonton Symptom Assessment System                                 55.51±15.78   2-90
  Palliative Performance Scale                                       33.81±17.81   10-90
                                                                     n             \%
  Gender                               Female                        36            19
                                       Male                          153           81
  Symptom                              Pain                          57            30.2
                                       Dyspnea                       153           81
                                       Cough                         56            29.6
                                       Hemoptysis                    11            5.8
                                       Tiredness                     53            28
                                       Lack of appetite              68            36
                                       Constipation                  8             4.2
                                       Insomnia                      13            6.9
                                       Nausea                        11            5.8
                                       Lack of well-being            14            7.4
  Diagnosis                            Lung Cancer                   156           82.5
                                       Brain Tumor                   1             0.5
                                       Colon Cancer                  3             1.6
                                       Laryngeal Cancer              2             1.1
                                       Malignant Melanoma            1             0.5
                                       Breast Cancer                 9             4.8
                                       Bladder Cancer                2             1.1
                                       Malign Pleural Mesothelioma   6             3.2
                                       Gastric Cancer                1             0.5
                                       Ovarian Cancer                1             0.5
                                       Esophageal Cancer             3             1.6
                                       Pancreatic Cancer             2             1.1
                                       Prostate Cancer               1             0.5
                                       Renal Cancer                  1             0.5

The mean age was 64.53 ± 11.60. Statistically significant parameters that differ between the two patient groups, which are classified by their survival being less or more than thirty days, were determined. Distant metastasis, brain metastasis, liver metastasis, symptom burden (ESAS) were higher in patients with short survival than others. Whereas, the level of albumin and prognostic indices (KPS and PPS) were lower in patients with short survival as shown in [Table 2](#table2){ref-type="table"}.

Significant correlations with short survival were PPS, ESAS, KPS, brain, liver, distant metastasis, leucocytes, neutrophil, MCHC, CRP, and ALB. The presence of the brain, liver, and distant metastasis, the level of CRP, leucocytes, neutrophil, the measurement of the symptom burden measurement (ESAS) were positively correlated with the short term of survival. However, the level of the albumin, MCHC and the prognostic measurements such as KPS and PPS were negatively correlated as shown in [Table 3](#table3){ref-type="table"}.

###### Differences in patients who died within 30-days and the others

                       Death within 30-days (n=125)   Others (n=64)   P                 
  -------------------- ------------------------------ --------------- -------- -------- ---------
  CRP                  152.49                         ±104.12         118.21   ±90.57   0.027
  ALB                  2.8                            ±0.48           3.08     ±0.59    0.001
  Leucocytes (AN)      14.18                          ±8.39           12.24    ±6.10    0.102
  MCHC                 31.70                          ±1.49           32.23    ±1.23    0.016
  NE (AN)              11.88                          ±8.05           10.02    ±5.94    0.102
  Distant Metastasis   35                             28%             7        10.9%    0.009
  Brain Metastasis     18                             14.4%           3        4.7%     0.051
  Liver Metastasis     19                             15.2%           3        4.7%     0.033
  KPS                  26.88                          ±13.16          44.53    ±19.43   \<0.001
  ESAS                 59.18                          ±13.77          48.34    ±17.05   \<0.001
  PPS                  27.92                          ±13.81          45.31    ±19.19   \<0.001

###### The Correlations

  Death within 30-days   Correlation   p
  ---------------------- ------------- ---------
  CRP                    0.151         0.038
  ALB                    -0.223        0.002
  Leucocytes (AN)        0.146         0.046
  MCHC                   -0.183        0.012
  NE (AN)                0.153         0.036
  Distant Metastasis     0.194         0.007
  Brain Metastasis       0.146         0.045
  Liver Metastasis       0.155         0.033
  KPS                    -0.460        \<0.001
  ESAS                   0.317         \<0.001
  PPS                    -0.452        \<0.001

###### True and Predicted Classes of Logistic Regression and ANN

                                                                             True Class             
  ---------------------------- ---------------------- ---------------------- ---------------------- -------
                                                      Predicted Class        Death within 30-days   Other
  Artificial Neural Networks   Training               Death within 30-days   77                     25
  Other                        8                      23                                            
  Cross-Validation             Death within 30-days   18                     4                      
  Other                        2                      4                                             
  Test                         Death within 30-days   20                     3                      
  Other                        0                      5                                             
  Total                        Death within 30-days   115                    32                     
  Other                        10                     32                                            
  Logistic Regression          Total                  Death within 30-days   105                    31
  Other                        20                     33                                            

The logistic regression model and ANN model are both trained using correlated parameters as the input variables for survival prediction and for investigating their influence. The results of the classification are given in [Table 4](#table4){ref-type="table"}.

The logistic regression model had an AUC value of 0.76 as shown in [Figure 1](#fig1){ref-type="fig"}. However, the ANN model achieved a better AUC value of 0.86 than the logistic regression model as shown in [Figure 2](#fig2){ref-type="fig"} for all three parts of the dataset. Additionally, the ANN model showed 89.3% prediction accuracy while logistic regression model showed 73.0%, as summarized in [Table 5](#table5){ref-type="table"}.

###### Accuracy, Sensitivity, Specificity and AUC of LR and ANN results

  Method                       Accuracy   Sensitivity   Specificity   AUC
  ---------------------------- ---------- ------------- ------------- ------
  Artificial Neural Networks   89.3%      38%           100%          0.86
  Logistic Regression          73.0%      48%           84%           0.76

![ROC Curve of Logistic Regression Classifier](AIM-28-108-g001){#fig1}

![ROC Curve of ANN Classifier for Training, Cross-Validation and Testing Data Sets](AIM-28-108-g002){#fig2}

5.. DISCUSSION {#sec5}
==============

Accurate prediction of cancer patients' survival is valuable for managing expectations, planning of care, and end-of-life. It is critical in the triangle of patients, caregivers/relatives, and clinicians ([@ref15], [@ref16]). A meta-analysis by White et al. reported that that clinicians' predictions are frequently inaccurate in palliative care ([@ref17]).

There are several prognostic evaluation tools such as PPS, KPS in a palliative care setting. Many studies compare ANN with other statistical models such as logistic regression. In a study comparing the logistic regression and the ANN model in predicting hospital mortality after hepatocellular carcinoma operation, it was shown that the ANN model provides a more accurate estimation ([@ref23]). Additionally, it is reported that the ANN model was more accurate in predicting 5-year mortality than multiple logistic regression in breast cancer patients after surgery ([@ref24]). In the study of Faradmal et al., the ANN model predicts breast cancer relapse better than the logistic regression model ([@ref7]). However, over time, both methods showed reducing the performance of prediction.

Similarly, this study, which also used palliative care patient data for the ANN model, we found better AUC value (0.86) than the logistic regression to predict survival. However, there are some opposing studies. These studies reported that the ANN model was not superior to the traditional models for prediction, which would be related to the data structure ([@ref21]). If the factor and response relationship in the data sample is unknown, the ANN model is better than traditional models to predict this relationship ([@ref1]). ANN model may rapidly recognize non-linear patterns, linear patterns even probable effects ([@ref25]).

The aim of our study was to compare two prediction models and to predict the short survival of the patients who were hospitalized in the palliative care service. For this reason, we determined the parameters that are correlated with survival from patient data. When we use the parameters that have a significant correlation with the survival as the ANN input parameters, we found that the model has determined the actual survival with high accuracy (89.3%).

These parameters used in our algorithm have been found to have relations with survival individually. Additionally, the ANN model showed a fairly good prediction ability. ANN classification model was used as a model to test and confirm the factors in the clinic and their effects on survival relationships in our study.

This algorithm contains data from laboratory parameters such as CRP, ALB, leucocytes, neutrophil, MCHC, and performance measurements such as KPS and PPS. Furthermore, the patient's symptom load (ESAS) and metastasis status were also included. These algorithm components are already associated with shorter survival, regarding the results obtained from other studies. In our study, it has been used as a collective algorithm and it is composed of parameters which have been determined by traditional statistical methods.

MCHC, which is a component of our algorithm, has a role in predicting short survival. MCHC is the average hemoglobin level in the erythrocyte. A few studies are showing the relevance of MCHC to survival. MCHC was negatively correlated with survival in our study. Increased MCHC level in hospitalized patients with acute myocardial infarction is associated with decreased hospitalization time and one-year mortality. Continuing inflammatory response may lead to iron deficiency, which decreases MCHC ([@ref26]-[@ref29]).

Several studies have shown that a high level of CRP correlates with patients with poorer prognosis in patients with resectable lung cancer. Besides, the CRP level was associated with reduced serum albumin, resulting in progressive weight loss, poor performance, the higher mortality rate in cancer patients ([@ref30]-[@ref32]).

The level of albumin can reveal the nutritional status of patients and correlates with short survival in advanced cancer. Cancer is in inflammation state with a low level of albumin. The systemic inflammatory response was found related to poor survival in cancer patients ([@ref33], [@ref34]). In our study, CRP and albumin were selected as algorithm component in the ANN model due to the relationship with poor survival.

Neutrophil and leukocyte count were also included in our algorithm. Neutrophilia and leukocytosis were important factors for survival prediction for this study. It was reported that both neutropenia and leukocytosis (mainly due to neutrophils) have been related to a poor course in cancer patients by another study, also ([@ref35]). Tumor related leukocytosis and neutrophilia may result from granulocyte colony-stimulating factors sourced from the solid tumor ([@ref36], [@ref37]). The relation between neutrophilia and lower performance score was shown ([@ref38]). Neutrophils ease invasion-metastasis cascade, repressing natural killer cell activity and enhancing the extravasation of tumor cells ([@ref39]).

We thought that patient's symptom load was crucial and it is selected as another parameter of this study for ANN and logistic regression models. Symptom burden measurement (ESAS) was positively correlated with the short term of survival in our study, similar to another study. McGee et al. demonstrated that ESAS was as a prognostic tool and could complement ECOG (Eastern Cooperative Oncology Group performance status) in the estimation of survival in advanced lung cancer ([@ref40]).

The association of survival with performance status measurements in terminally ill cancer patients was studied many times. The KPS and ECOG status were the two most frequent measurements ([@ref41]). Even if, the performance status was accepted as a significant prognostic factor for survival, possible acute influences should be considered ([@ref35]). The KFS and PPS that are used as the palliative performance tools, were correlated with short survival in this study.

Additionally, the presence of metastasis has also been determined in several studies as a prognostic factor in advanced cancer patients ([@ref42]). This study showed the presence of distant metastasis, especially brain and liver involvement, is correlated with short survival.

Since the correlation of the above-mentioned factors with short survival was found in several studies, the correlations between these factors were also found in our study, and we developed modeling for ANN and logistic regression to create a predictive algorithm from these factors for survival. Thus, we have tested the accuracy of them or survival prediction by applying both ANN and logistic regression methods. We found that ANN provides a more accurate estimation than logistic regression.

A limitation of this study is that most of the cases are lung cancer patients because our center is in a respiratory reference hospital. The effectivity of the model can be improved with the use of artificial neural networks including more cases and covering all cancer types.

6.. CONCLUSION {#sec6}
==============

This study showed that ANN recognizes linear, non-linear even influence effect and can be used as a 30-days survival prediction algorithm for cancer patients. The usefulness of this algorithm can be determined by applying to a large number of palliative patients in future prospective studies. As suggested by the literature, our study also contributes to the validation of ANN for future prognostication ([@ref43]). We think that the ANN model is an important statistical method for survival prediction that can include a considerable number of parameters and provides the opportunity to practice in very large patient populations.
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